Trial Profile
A Double Blind, Randomized, Multicenter Stratified Study to Assess the Safety of an Intravenous Staphylococcus Aureus Immune Globulin (Human) [Altastaph] in Low-Birth-Weight-Neonates
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Jul 2022
Price :
$35
*
At a glance
- Drugs Staphylococcus aureus immune globulin (Primary)
- Indications Staphylococcal infections
- Focus Adverse reactions
- Sponsors Biota Pharmaceuticals
- 06 Jun 2014 New trial record